Changes to the Code
S. 529 · Capping Prescription Costs Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
26 U.S.C. § 9821 Cap on prescription drug cost-sharing New section
1 change the bill asks for here, 1 carried out
- Carried out:
Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by inserting after section 9820 the following:9821. Cap on prescription drug cost-sharing A group health plan shall ensure that any cost-sharing imposed under the plan with respect to prescription drugs covered by the plan does not exceed the limitations provided for under paragraph (5) of section 1302(c) of the Patient Protection and Affordable Care Act..
§ 9821
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 9821. [inserted: Cap on prescription drug cost-sharing] | ||||
| [inserted: A group health plan shall ensure that any cost-sharing imposed under the plan with respect to prescription drugs covered by the plan does not exceed the limitations provided for under paragraph (5) of section 1302(c) of the Patient Protection and Affordable Care Act.] | ||||
42 U.S.C. § 18022 Essential health benefits requirements
2 changes the bill asks for here, 2 carried out
- Carried out:
in paragraph (3)(A)(i), by inserting
, including cost-sharing with respect to prescription drugs covered by the plan
aftercharges
; and - Carried out:
by adding at the end the following:
(5) Prescription drug cost-sharing.— (A) 2026.— For plan years beginning in 2026, the cost-sharing incurred under a health plan with respect to prescription drugs covered by the plan shall not exceed $2,000 per year for each enrolled individual, or $4,000 per year for each …
§ 18022(c)–(d)
Start of § 18022 to (c)(3) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (c)(3)(A) | (A) In general | (A) In general | ||
| The term “cost-sharing” includes— | The term “cost-sharing” includes— | |||
| (c)(3)(A)(i) | (i) | (i) | ||
| deductibles, coinsurance, copayments, or similar charges; and | deductibles, coinsurance, copayments, or similar charges[inserted: , including cost-sharing with respect to prescription drugs covered by the plan]; and | |||
| (c)(3)(A)(ii) | (ii) | (ii) | ||
| any other expenditure required of an insured individual which is a qualified medical expense (within the meaning of section 223(d)(2) of title 26) with respect to essential health benefits covered under the plan. | any other expenditure required of an insured individual which is a qualified medical expense (within the meaning of section 223(d)(2) of title 26) with respect to essential health benefits covered under the plan. | |||
| (c)(3)(B) | (B) Exceptions | (B) Exceptions | ||
| Such term does not include premiums, balance billing amounts for non-network providers, or spending for non-covered services. | Such term does not include premiums, balance billing amounts for non-network providers, or spending for non-covered services. | |||
| (c)(4) | (4) Premium adjustment percentage | (4) Premium adjustment percentage | ||
| For purposes of paragraph (1)(B)(i), the premium adjustment percentage for any calendar year is the percentage (if any) by which the average per capita premium for health insurance coverage in the United States for the preceding calendar year (as estimated by the Secretary no later than October 1 of such preceding calendar year) exceeds such average per capita premium for 2013 (as determined by the Secretary). | For purposes of paragraph (1)(B)(i), the premium adjustment percentage for any calendar year is the percentage (if any) by which the average per capita premium for health insurance coverage in the United States for the preceding calendar year (as estimated by the Secretary no later than October 1 of such preceding calendar year) exceeds such average per capita premium for 2013 (as determined by the Secretary). | |||
| (c)(5) | (5) [inserted: Prescription drug cost-sharing.—] | |||
| (c)(5)(A) | (A) [inserted: 2026.—] | |||
| [inserted: For plan years beginning in 2026, the cost-sharing incurred under a health plan with respect to prescription drugs covered by the plan shall not exceed $2,000 per year for each enrolled individual, or $4,000 per year for each family.] | ||||
| (c)(5)(B) | (B) [inserted: 2027 and later.—] | |||
| (c)(5)(B)(i) | (i) [inserted: In general.—] | |||
| [inserted: In the case of any plan year beginning in a calendar year after 2026, the limitation under this paragraph shall be equal to the applicable dollar amount under subparagraph (A) for plan years beginning in 2026, increased by an amount equal to the product of that amount and the medical care component of the consumer price index for all urban consumers (as published by the Bureau of Labor Statistics) for that year.] | ||||
| (c)(5)(B)(ii) | (ii) [inserted: Adjustment to amount.—] | |||
| [inserted: If the amount of any increase under clause (i) is not a multiple of $5, such increase shall be rounded to the next lowest multiple of $5.] | ||||
| (d) | (d) Levels of coverage | (d) Levels of coverage | ||
| (d)(1) | (1) Levels of coverage defined | (1) Levels of coverage defined | ||
| The levels of coverage described in this subsection are as follows: | The levels of coverage described in this subsection are as follows: | |||
Rest of § 18022 unchanged